Coya Therapeutics (COYA) Current Taxes (2023 - 2024)
Coya Therapeutics' (COYA) quarterly Current Taxes came in at $723852.0 in Q1 2024, little changed quarter-over-quarter from $723852.0 in Q4 2023.
Powered by 
Analysis
Coya Therapeutics (COYA) Current Taxes (2023 - 2024) Analysis & Trends
Coya Therapeutics has disclosed Current Taxes across 2 years of filings, most recently posting $723852.0 for Q1 2024.
- In Q1 2024, Current Taxes changed N/A year-over-year to $723852.0; the TTM figure through Mar 2024 stood at $723852.0 (changed N/A YoY), while the FY2023 annual figure was $723852.0, changed N/A from the prior year.
- Current Taxes came in at $723852.0 for Q1 2024 at Coya Therapeutics, roughly flat from $723852.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $723852.0 in Q4 2023 to a low of $723852.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 49.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 86.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 74.18 Mn |
| 10 | Coya Therapeutics | 106.14 Mn | 62.94 Mn | - | - |